FDA Grants Orphan Drug Designation To Prometic's PBI-4050 Drug For The Treatment Of Alstr??m Syndrome - BioLegacy Research

FDA Grants Orphan Drug Designation To Prometic's PBI-4050 Drug For The Treatment Of Alstr??m Syndrome

Post author:Sam
Post published:March 2, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace